Literature DB >> 25529450

Deficiency of the 15-kDa selenoprotein led to cytoskeleton remodeling and non-apoptotic membrane blebbing through a RhoA/ROCK pathway.

Jeyoung Bang1, Mihyun Jang2, Jang Hoe Huh2, Ji-Woon Na2, Myoungsup Shim3, Bradley A Carlson4, Ryuta Tobe4, Petra A Tsuji5, Vadim N Gladyshev6, Dolph L Hatfield4, Byeong Jae Lee7.   

Abstract

The 15-kDa selenoprotein (Sep15) has been implicated in etiology of some types of cancer. Herein, inducible RNAi cell lines were established and cell morphology and motility were analyzed. The majority of Sep15-deficient cells (>95%) formed membrane blebs in a dynamic manner. Blebbing cells transformed cell morphology from a normal flat spindle shape to a spherical morphology. In blebbing cells, actin fibers moved to the cell periphery, covering and obscuring visualization of α-tubulin. Bleb formation was suppressed by the inhibitors of Rho-associated protein kinase (ROCK), RhoA or myosin light chain (MLC), restoring blebbing cells to wild-type morphology. RhoA activation and phosphorylation of myosin phosphatase target subunit 1 was induced by Sep15 knockdown. Sep15-deficient cells were non-apoptotic, and displayed a distinct relative localization of F-actin and α-tubulin from typical apoptotic blebbing cells. Our data suggest that Sep15 in Chang liver cells regulates the pathway that antagonizes RhoA/ROCK/MLC-dependent non-apoptotic bleb formation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  15-kDa selenoprotein; Apoptosis; Cytoskeletal protein; Membrane blebbing; Selenium

Mesh:

Substances:

Year:  2014        PMID: 25529450      PMCID: PMC4758352          DOI: 10.1016/j.bbrc.2014.12.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Rho-kinase controls cell shape changes during cytokinesis.

Authors:  Gilles R X Hickson; Arnaud Echard; Patrick H O'Farrell
Journal:  Curr Biol       Date:  2006-02-21       Impact factor: 10.834

Review 2.  Blebs lead the way: how to migrate without lamellipodia.

Authors:  Guillaume Charras; Ewa Paluch
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-16       Impact factor: 94.444

3.  Human selenophosphate synthetase 1 has five splice variants with unique interactions, subcellular localizations and expression patterns.

Authors:  Jin Young Kim; Kwang Hee Lee; Myoung Sup Shim; Hyein Shin; Xue-Ming Xu; Bradley A Carlson; Dolph L Hatfield; Byeong Jae Lee
Journal:  Biochem Biophys Res Commun       Date:  2010-05-22       Impact factor: 3.575

4.  Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology.

Authors:  E Kumaraswamy; A Malykh; K V Korotkov; S Kozyavkin; Y Hu; S Y Kwon; M E Moustafa; B A Carlson; M J Berry; B J Lee; D L Hatfield; A M Diamond; V N Gladyshev
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

5.  Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing.

Authors:  M Sebbagh; C Renvoizé; J Hamelin; N Riché; J Bertoglio; J Bréard
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

6.  Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype.

Authors:  Sinoula Apostolou; Julian O Klein; Yasuhiro Mitsuuchi; Justin N Shetler; Poulikos I Poulikakos; Suresh C Jhanwar; Warren D Kruger; Joseph R Testa
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

Review 7.  The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  IUBMB Life       Date:  2007-01       Impact factor: 3.885

Review 8.  The role of selenium in chronic disease.

Authors:  Maria G Boosalis
Journal:  Nutr Clin Pract       Date:  2008 Apr-May       Impact factor: 3.080

9.  Deficiency in the 15 kDa selenoprotein inhibits human colon cancer cell growth.

Authors:  Petra A Tsuji; Salvador Naranjo-Suarez; Bradley A Carlson; Ryuta Tobe; Min-Hyuk Yoo; Cindy D Davis
Journal:  Nutrients       Date:  2011-09-05       Impact factor: 5.717

10.  Reassembly of contractile actin cortex in cell blebs.

Authors:  Guillaume T Charras; Chi-Kuo Hu; Margaret Coughlin; Timothy J Mitchison
Journal:  J Cell Biol       Date:  2006-11-06       Impact factor: 10.539

View more
  11 in total

1.  Protein Partners of Selenoprotein SELM and the Role of Selenium Compounds in Regulation of Its Expression in Human Cancer Cells.

Authors:  E G Varlamova; M V Goltyaev; E E Fesenko
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

2.  Growth cone macropinocytosis of neurotrophin receptor and neuritogenesis are regulated by neuron navigator 1.

Authors:  Regina M Powers; Ray Daza; Alanna E Koehler; Julien Courchet; Barbara Calabrese; Robert F Hevner; Shelley Halpain
Journal:  Mol Biol Cell       Date:  2022-03-30       Impact factor: 3.612

3.  Selenophosphate synthetase 1 is an essential protein with roles in regulation of redox homoeostasis in mammals.

Authors:  Ryuta Tobe; Bradley A Carlson; Jang Hoe Huh; Nadia P Castro; Xue-Ming Xu; Petra A Tsuji; Sang-Goo Lee; Jeyoung Bang; Ji-Woon Na; Young-Yun Kong; Daniel Beaglehole; Eileen Southon; Harold Seifried; Lino Tessarollo; David S Salomon; Ulrich Schweizer; Vadim N Gladyshev; Dolph L Hatfield; Byeong Jae Lee
Journal:  Biochem J       Date:  2016-05-16       Impact factor: 3.857

Review 4.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

5.  Cell Proliferation and Motility Are Inhibited by G1 Phase Arrest in 15-kDa Selenoprotein-Deficient Chang Liver Cells.

Authors:  Jeyoung Bang; Jang Hoe Huh; Ji-Woon Na; Qiao Lu; Bradley A Carlson; Ryuta Tobe; Petra A Tsuji; Vadim N Gladyshev; Dolph L Hatfield; Byeong Jae Lee
Journal:  Mol Cells       Date:  2015-02-27       Impact factor: 5.034

Review 6.  Involvement of Membrane Blebbing in Immunological Disorders and Cancer.

Authors:  Maitham A Khajah; Yunus A Luqmani
Journal:  Med Princ Pract       Date:  2015-11-26       Impact factor: 1.927

7.  AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin.

Authors:  Junting Cai; Jianxin Wei; Shuang Li; Tomeka Suber; Jing Zhao
Journal:  Mediators Inflamm       Date:  2017-02-27       Impact factor: 4.711

Review 8.  Role of Selenoprotein F in Protein Folding and Secretion: Potential Involvement in Human Disease.

Authors:  Bingyu Ren; Min Liu; Jiazuan Ni; Jing Tian
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

9.  The interaction of selenoprotein F (SELENOF) with retinol dehydrogenase 11 (RDH11) implied a role of SELENOF in vitamin A metabolism.

Authors:  Jing Tian; Jiapan Liu; Jieqiong Li; Jingxin Zheng; Lifang Chen; Yujuan Wang; Qiong Liu; Jiazuan Ni
Journal:  Nutr Metab (Lond)       Date:  2018-01-22       Impact factor: 4.169

10.  Resveratrol enhances vascular reactivity in mice following lipopolysaccharide challenge via the RhoA-ROCK-MLCP pathway.

Authors:  Xu-Qing Wang; Yu-Ping Zhang; Li-Min Zhang; Niu-Niu Feng; Ming-Zhu Zhang; Zi-Gang Zhao; Chun-Yu Niu
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.